BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

508 related articles for article (PubMed ID: 8832986)

  • 1. Elevated serum prolactin or elevated prolactin/cortisol ratio are associated with autoimmune processes in systemic lupus erythematosus and other connective tissue diseases.
    Neidhart M
    J Rheumatol; 1996 Mar; 23(3):476-81. PubMed ID: 8832986
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biologic activity and plasma clearance of prolactin-IgG complex in patients with systemic lupus erythematosus.
    Leaños-Miranda A; Chávez-Rueda KA; Blanco-Favela F
    Arthritis Rheum; 2001 Apr; 44(4):866-75. PubMed ID: 11315926
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Presence of antinucleosome autoantibodies in a restricted set of connective tissue diseases: antinucleosome antibodies of the IgG3 subclass are markers of renal pathogenicity in systemic lupus erythematosus.
    Amoura Z; Koutouzov S; Chabre H; Cacoub P; Amoura I; Musset L; Bach JF; Piette JC
    Arthritis Rheum; 2000 Jan; 43(1):76-84. PubMed ID: 10643702
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiprolactin autoantibodies in systemic lupus erythematosus: frequency and correlation with prolactinemia and disease activity.
    Leaños-Miranda A; Pascoe-Lira D; Chávez-Rueda KA; Blanco-Favela F
    J Rheumatol; 2001 Jul; 28(7):1546-53. PubMed ID: 11469460
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased serum levels of immunoglobulins, C-reactive protein, type 1 and type 2 cytokines in patients with mixed connective tissue disease.
    Bakri Hassan A; Rönnelid J; Gunnarsson I; Karlsson G; Berg L; Lundberg I
    J Autoimmun; 1998 Oct; 11(5):503-8. PubMed ID: 9802936
    [TBL] [Abstract][Full Text] [Related]  

  • 6. No correlation between prolactin levels and clinical activity in patients with systemic lupus erythematosus.
    Buskila D; Lorber M; Neumann L; Flusser D; Shoenfeld Y
    J Rheumatol; 1996 Apr; 23(4):629-32. PubMed ID: 8730116
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elevated serum B lymphocyte stimulator levels in patients with systemic immune-based rheumatic diseases.
    Cheema GS; Roschke V; Hilbert DM; Stohl W
    Arthritis Rheum; 2001 Jun; 44(6):1313-9. PubMed ID: 11407690
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elevated bioactive prolactin levels in systemic lupus erythematosus--association with disease activity.
    Pacilio M; Migliaresi S; Meli R; Ambrosone L; Bigliardo B; Di Carlo R
    J Rheumatol; 2001 Oct; 28(10):2216-21. PubMed ID: 11669159
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Altered diurnal rhythm of prolactin in systemic sclerosis.
    Hilty C; Brühlmann P; Sprott H; Gay RE; Michel BA; Gay S; Neidhart M
    J Rheumatol; 2000 Sep; 27(9):2160-5. PubMed ID: 10990228
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Altered function of the hypothalamic stress axes in patients with moderately active systemic lupus erythematosus. II. Dissociation between androstenedione, cortisol, or dehydroepiandrosterone and interleukin 6 or tumor necrosis factor.
    Zietz B; Reber T; Oertel M; Glück T; Schölmerich J; Straub RH
    J Rheumatol; 2000 Apr; 27(4):911-8. PubMed ID: 10782815
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High frequency of abnormal levels of IgA anti-beta2-glycoprotein I antibodies in patients with systemic lupus erythematosus: relationship with antiphospholipid syndrome.
    Fanopoulos D; Teodorescu MR; Varga J; Teodorescu M
    J Rheumatol; 1998 Apr; 25(4):675-80. PubMed ID: 9558168
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hyperprolactinemia in males with systemic lupus erythematosus.
    Mok CC; Lau CS; Lee KW; Wong RW
    J Rheumatol; 1998 Dec; 25(12):2357-63. PubMed ID: 9858430
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The value of IgA antiphospholipid testing for diagnosis of antiphospholipid (Hughes) syndrome in systemic lupus erythematosus.
    Bertolaccini ML; Atsumi T; Escudero Contreras A; Khamashta MA; Hughes GR
    J Rheumatol; 2001 Dec; 28(12):2637-43. PubMed ID: 11764209
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship between endocrine, immune, and clinical variables in patients with systemic lupus erythematosus.
    Rovenský J; Juránková E; Rauová L; Blazícková S; Lukác J; Veselková Z; Jezová D; Vigas M
    J Rheumatol; 1997 Dec; 24(12):2330-4. PubMed ID: 9415637
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum free prolactin concentrations in patients with systemic lupus erythematosus are associated with lupus activity.
    Leaños-Miranda A; Cárdenas-Mondragón G
    Rheumatology (Oxford); 2006 Jan; 45(1):97-101. PubMed ID: 16249247
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum autoantibodies profile and increased levels of circulating intercellular adhesion molecule-1: a reflection of the immunologically mediated systemic vasculopathy in rheumatic diseases?
    Kuryliszyn-Moskal A; Klimiuk PA; Sierakowski S
    Arch Immunol Ther Exp (Warsz); 2001; 49(6):423-30. PubMed ID: 11814236
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship of interleukin-12 and interleukin-13 imbalance with class-specific rheumatoid factors and anticardiolipin antibodies in systemic lupus erythematosus.
    Spadaro A; Scrivo R; Bombardieri M; Riccieri V; Rinaldi T; Taccari E; Valesini G
    Clin Rheumatol; 2003 May; 22(2):107-11. PubMed ID: 12740674
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-beta2-glycoprotein I, anti-prothrombin and anticardiolipin antibodies in a longitudinal study of patients with systemic lupus erythematosus and the antiphospholipid syndrome.
    Inanç M; Donohoe S; Ravirajan CT; Radway-Bright EL; Mackie I; Machin S; Isenberg DA
    Br J Rheumatol; 1998 Oct; 37(10):1089-94. PubMed ID: 9825748
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiendothelial cell antibodies and their relation to pulmonary hypertension in systemic lupus erythematosus.
    Yoshio T; Masuyama J; Sumiya M; Minota S; Kano S
    J Rheumatol; 1994 Nov; 21(11):2058-63. PubMed ID: 7869310
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autoantibodies to the translational suppressors T cell intracytoplasmic antigen 1 and T cell intracytoplasmic antigen 1-related protein in patients with rheumatic diseases: increased prevalence in systemic lupus erythematosus and systemic sclerosis and correlation with clinical features.
    Jimenez-Boj E; Kedersha N; Tohidast-Akrad M; Karlhofer FM; Stummvoll G; Zimmermann C; Ulrich W; Guiducci S; Hoefler E; Aringer M; Schett G; Matucci-Cerinic M; Smolen JS; Steiner G
    Arthritis Rheum; 2008 May; 58(5):1226-36. PubMed ID: 18438838
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.